Company Overview

Company Profile

Company Name Mebix, Inc.
Established May 21, 2001
President Yuki Murabayashi
Capital 60,000,000 yen (As of March 1, 2024)
Shareholder Composition M3, Inc. (100%)
Location of Head Office Akasaka Intercity
1-11-44 Akasaka, Minato-ku, Tokyo
107-0052 JAPAN

Toranomon Office

Location 10F. Toranomon 33 Mori Building
3-8-21 Toranomon, Minato-ku, Tokyo
105-0001 JAPAN
TEL +81-3-4362-4500
FAX +81-3-4362-4517

Osaka Office

Location 9F. Aioi Nissay Dowa Insurance Midosuji Building
3-6-1 Hirano-cho, Chuo-ku, Osaka-shi, Osaka
541-0046 JAPAN
TEL +81-6-6226-0657
FAX +81-6-6226-0672

Access Map

Toranomon Office:
10F. Toranomon 33 Mori Building, 3-8-21 Toranomon, Minato-ku, Tokyo 105-0001 JAPAN

  • Walk for 4 minutes from Kamiyacho Station of Hibiya Line (exit 3)
  • Walk for 6 minutes from Toranomon Station of Ginza Line (exit 4)
  • Walk for 11 minutes from Tameike-Sanno Station of Ginza & Nanboku Line (exit 13)
  • Walk for 14 minutes from Roppongi-Itchome Station of Nanboku Line (exit 3)

Osaka Office:
9F. Aioi Nissay Dowa Sonpo Midousuji Building, 3-6-1 Hiranotyo, Chuo-ku, Osaka city, Osaka 541-0046 JAPAN

  • Walk for 3 minutes from Yodoyabashi Station of Midousuji Line
  • Walk for 4 minutes from Honmachi Station of Midousuji Line
  • Walk for 6 minutes from Yodoyabashi Station of Keihan Line

Support for Clinical Research

Comprehensive Picture of Services

Mebix conducts specialized comprehensive support for clinical research.
From study design proposals and drafting protocol to case report data collection, data management,
statistical analysis and drafting articles, we offer total support for all aspects of clinical research.

Clinical Research Flow

Contract History

Contracts by Field

Contracts by Service

Qualitative Research Support

We provide high-quality qualitative research support, leveraging our extensive experience in the healthcare sector and deep academic expertise.

Advanced Expertise and Academic Approach

Our projects are led by a dedicated research team with a profound understanding of qualitative methodologies. Our members bring diverse academic backgrounds—ranging from medicine and public health to sociology—ensuring a multi-faceted perspective on every study.
Our interviewers possess specialized medical knowledge, allowing them to conduct in-depth explorations while accurately contextualizing the clinical environment and patient experiences. With a proven track record across a wide spectrum of therapeutic areas—from rare diseases to chronic conditions—we propose optimal research designs tailored to your specific objectives.

Rigorous Analysis and Adherence to International Guidelines

We ensure the highest standards of research integrity by adhering to international reporting guidelines, such as COREQ (Consolidated Criteria for Reporting Qualitative Research). To guarantee the credibility of our findings, we employ researcher triangulation, where multiple analysts perform independent coding.
Furthermore, we can facilitate strategic discussions with your partner Key Opinion Leaders (KOLs) and specialists to extract deeper clinical insights from the data. By utilizing professional qualitative data analysis software (QDAS), we ensure transparency by maintaining a structured record of the analytical process.

> For more information, please contact us.

Group

M3 Inc.M3 Inc.

Mebix is an M3 group company.
M3 operates m3.com, the nation’s largest dedicated medical portal site, which has over 210,000 physicians across the country as registered members (as of November 2011.)
We are able to collaborate in a variety of ways regarding support for clinical research and post-marketing surveillance, and we make proposals which could only come from the M3 group.

Clinical Porter, Inc.Clinical Porter, Inc.

Clinical Porter is a Mebix group company.
It facilitates appropriate study administration for the medical institutions that participate in our clinical research.
Clinical Porter serves as a mediator between medical institutions and individuals participating in studies, supporting clinical research so that it may be conducted appropriately and smoothly.

Other Group Companies

〔SMO business〕

〔CRO business〕

〔e-Infrastructure preparation〕